The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial cancer.
 
Cinthia Marie Gonzalez
No Relationships to Disclose
 
Emmet Jordan
No Relationships to Disclose
 
Emily C. Zabor
No Relationships to Disclose
 
Brooke Elizabeth Kania
No Relationships to Disclose
 
Ashley Marie Regazzi
No Relationships to Disclose
 
Irina Ostrovnaya
No Relationships to Disclose
 
Gopa Iyer
No Relationships to Disclose
 
Dean F. Bajorin
No Relationships to Disclose
 
Richard Martin Bambury
No Relationships to Disclose
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Oncogenex; Onyx